Franklin-based BioMimetic Therapeutics said it has increased its cash balance by $39 million in a deal with Deutsche Bank AG. The money is essentially a loan with BioMimetic's auction-rate securities portfolio as the collateral. BioMimetic borrowed 70 percent of the value of the portfolio, which has been affected by the meltdown in credit markets.
Fresenius opens new centerFresenius Medical Care North America, based in Waltham, Mass., has opened an advanced dialysis treatment center in Centerville, Tenn.
The company is a subsidiary of Fresenius AG, which acquired the former Nashville-based Renal Care Group in 2006.
Dow’s drop befuddles analysts
Investor Report: Investment Affordability
Investor Report: Cash for Future Equity
